Cipher Pharmaceuticals Inc. (CPH.TO)
CAD 14.56
(3.41%)
CAD 14.56
(3.41%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 86.03 Million USD | 16.61% |
| 2022 | 73.77 Million USD | 42.84% |
| 2021 | 51.65 Million USD | 16.66% |
| 2020 | 44.27 Million USD | -4.69% |
| 2019 | 46.45 Million USD | -16.58% |
| 2018 | 55.68 Million USD | -11.79% |
| 2017 | 63.13 Million USD | -18.44% |
| 2016 | 77.4 Million USD | -29.4% |
| 2015 | 109.64 Million USD | 884.67% |
| 2014 | 11.13 Million USD | -78.66% |
| 2013 | 52.17 Million USD | 136.4% |
| 2012 | 22.06 Million USD | 53.71% |
| 2011 | 14.35 Million USD | -11.21% |
| 2010 | 16.17 Million USD | 14.23% |
| 2009 | 14.15 Million USD | 5.2% |
| 2008 | 13.45 Million USD | -28.8% |
| 2007 | 18.9 Million USD | -2.11% |
| 2006 | 19.3 Million USD | -12.78% |
| 2005 | 22.13 Million USD | -31.59% |
| 2004 | 32.36 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 92.55 Million USD | 7.58% |
| 2024 Q2 | 93.91 Million USD | 1.47% |
| 2023 Q4 | 86.03 Million USD | -4.97% |
| 2023 Q3 | 90.52 Million USD | 12.3% |
| 2023 FY | 86.03 Million USD | 16.61% |
| 2023 Q1 | 76.96 Million USD | 4.32% |
| 2023 Q2 | 80.61 Million USD | 4.75% |
| 2022 Q4 | 73.77 Million USD | 28.45% |
| 2022 FY | 73.77 Million USD | 42.84% |
| 2022 Q1 | 53.99 Million USD | 4.54% |
| 2022 Q2 | 55.95 Million USD | 3.62% |
| 2022 Q3 | 57.43 Million USD | 2.65% |
| 2021 Q3 | 46.39 Million USD | -3.5% |
| 2021 FY | 51.65 Million USD | 16.66% |
| 2021 Q2 | 48.07 Million USD | 3.82% |
| 2021 Q4 | 51.65 Million USD | 11.33% |
| 2021 Q1 | 46.3 Million USD | 4.58% |
| 2020 Q1 | 45.55 Million USD | -1.95% |
| 2020 Q3 | 46.08 Million USD | 0.16% |
| 2020 Q4 | 44.27 Million USD | -3.93% |
| 2020 FY | 44.27 Million USD | -4.69% |
| 2020 Q2 | 46.01 Million USD | 1.01% |
| 2019 Q1 | 54.1 Million USD | -2.84% |
| 2019 Q4 | 46.45 Million USD | 1.26% |
| 2019 Q3 | 45.87 Million USD | -13.37% |
| 2019 Q2 | 52.95 Million USD | -2.12% |
| 2019 FY | 46.45 Million USD | -16.58% |
| 2018 Q2 | 60.99 Million USD | 21.25% |
| 2018 FY | 55.68 Million USD | -11.79% |
| 2018 Q4 | 55.68 Million USD | 1.95% |
| 2018 Q3 | 54.62 Million USD | -10.45% |
| 2018 Q1 | 50.3 Million USD | -20.31% |
| 2017 FY | 63.13 Million USD | -18.44% |
| 2017 Q4 | 63.13 Million USD | 11.73% |
| 2017 Q2 | 54.61 Million USD | -30.23% |
| 2017 Q1 | 78.27 Million USD | 1.13% |
| 2017 Q3 | 56.5 Million USD | 3.46% |
| 2016 FY | 77.4 Million USD | -29.4% |
| 2016 Q2 | 109.8 Million USD | 0.13% |
| 2016 Q3 | 86.45 Million USD | -21.27% |
| 2016 Q4 | 77.4 Million USD | -10.46% |
| 2016 Q1 | 109.66 Million USD | 0.02% |
| 2015 FY | 109.64 Million USD | 884.67% |
| 2015 Q1 | 63.95 Million USD | -3.2% |
| 2015 Q4 | 109.64 Million USD | 6.42% |
| 2015 Q3 | 103.03 Million USD | -3.01% |
| 2015 Q2 | 106.23 Million USD | 66.12% |
| 2014 Q3 | 62.44 Million USD | 10.57% |
| 2014 Q4 | 66.06 Million USD | 5.78% |
| 2014 Q1 | 50.81 Million USD | -2.61% |
| 2014 FY | 11.13 Million USD | -78.66% |
| 2014 Q2 | 56.47 Million USD | 11.15% |
| 2013 Q3 | 30.68 Million USD | 13.71% |
| 2013 Q4 | 52.17 Million USD | 70.03% |
| 2013 FY | 52.17 Million USD | 136.4% |
| 2013 Q1 | 24.01 Million USD | 8.83% |
| 2013 Q2 | 26.98 Million USD | 12.35% |
| 2012 FY | 22.06 Million USD | 53.71% |
| 2012 Q3 | 21.26 Million USD | 8.21% |
| 2012 Q2 | 19.65 Million USD | 30.91% |
| 2012 Q1 | 15.01 Million USD | 4.55% |
| 2012 Q4 | 22.06 Million USD | 3.79% |
| 2011 Q3 | 14.67 Million USD | 1.19% |
| 2011 Q2 | 14.5 Million USD | -3.5% |
| 2011 FY | 14.35 Million USD | -11.21% |
| 2011 Q4 | 14.35 Million USD | -2.18% |
| 2011 Q1 | 15.03 Million USD | -7.05% |
| 2010 Q3 | 15.43 Million USD | -3.62% |
| 2010 Q2 | 16 Million USD | 0.34% |
| 2010 Q4 | 16.17 Million USD | 4.8% |
| 2010 FY | 16.17 Million USD | 14.23% |
| 2010 Q1 | 15.95 Million USD | 12.71% |
| 2009 Q3 | 14.39 Million USD | 7.69% |
| 2009 FY | 14.15 Million USD | 5.2% |
| 2009 Q2 | 13.37 Million USD | 11.99% |
| 2009 Q1 | 11.94 Million USD | -11.27% |
| 2009 Q4 | 14.15 Million USD | -1.69% |
| 2008 Q2 | 15.74 Million USD | -8.35% |
| 2008 Q4 | 13.45 Million USD | -17.33% |
| 2008 Q3 | 16.27 Million USD | 3.4% |
| 2008 FY | 13.45 Million USD | -28.8% |
| 2008 Q1 | 17.17 Million USD | -9.12% |
| 2007 Q3 | 20.1 Million USD | 13.07% |
| 2007 Q4 | 18.9 Million USD | -5.99% |
| 2007 FY | 18.9 Million USD | -2.11% |
| 2007 Q1 | 17.7 Million USD | -8.3% |
| 2007 Q2 | 17.78 Million USD | 0.41% |
| 2006 FY | 19.3 Million USD | -12.78% |
| 2006 Q4 | 19.3 Million USD | -13.18% |
| 2006 Q2 | 24.52 Million USD | -11.44% |
| 2006 Q3 | 22.23 Million USD | -9.32% |
| 2006 Q1 | 27.69 Million USD | 25.09% |
| 2005 Q3 | 24.61 Million USD | -13.25% |
| 2005 Q1 | 31.58 Million USD | 0.0% |
| 2005 Q4 | 22.13 Million USD | -10.07% |
| 2005 FY | 22.13 Million USD | -31.59% |
| 2005 Q2 | 28.37 Million USD | -10.14% |
| 2004 Q2 | 31.39 Million USD | -5.5% |
| 2004 Q1 | 33.21 Million USD | 0.0% |
| 2004 FY | 32.36 Million USD | 0.0% |
| 2004 Q3 | 31.14 Million USD | -0.77% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aurora Cannabis Inc. | 838.67 Million CAD | 89.742% |
| Avicanna Inc. | 21.97 Million CAD | -291.564% |
| Avant Brands Inc. | 82.55 Million CAD | -4.214% |
| Cardiol Therapeutics Inc. | 36.7 Million CAD | -134.414% |
| Crescita Therapeutics Inc. | 24.59 Million CAD | -249.748% |
| Knight Therapeutics Inc. | 945.49 Million CAD | 90.901% |
| MediPharm Labs Corp. | 63.93 Million CAD | -34.556% |
| OrganiGram Holdings Inc. | 298.45 Million CAD | 71.175% |
| Canopy Growth Corporation | 1.3 Billion CAD | 93.384% |
| Willow Biosciences Inc. | 6.67 Million CAD | -1189.24% |
| Auxly Cannabis Group Inc. | 261.9 Million CAD | 67.152% |